Miralles Gines Diego

Miralles Gines Diego is listed in filings as Director at Contineum Therapeutics, Inc. Class A Common Stock. This profile follows SEC Form 4 activity through May 19, 2026, including 5 public disclosures. Recent filings connect the profile to Contineum Therapeutics, Inc. Class A Common Stock (CTNM) and Artiva Biotherapeutics, Inc. (ARTV). The current snapshot covers public activity from Mar 17, 2025 to May 19, 2026. Reported amounts are shown as $196.8K to $22.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.